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The fine localization of melatonin and its receptors in the human salivary glands 
were reported in our previous works revealing, by transmission electron microsco-
py (TEM), that serous cells are able to store melatonin and to secrete it by regulated 
pathways (1, 2). Moreover, changing in morphology during secretion was observed 
after melatonin treatment by high resolution scanning electron microscopy (3). As in 
saliva of patients suffering from type 2 diabetes melatonin was reduced, we focused 
our study on salivary glands removed from diabetic subjects, in order to add diabetic 
data to our survey on melatonin and salivary glands. Aim of this investigation was 
to establish if diabetic status may affect subcellular melatonin distribution and traf-
fic. Bioptic samples of parotid and submandibular glands, removed from diabetic 
patients, were fixed, dehydrated, embedded in Epon Resin and processed to search 
for melatonin reactivity by the immunogold staining method. The labelling densi-
ty (expressed as number of gold particles per μm2/granule) and the percentage of 
melatonin-positive granules were estimated in diabetic samples. The resulting values 
were compared with those of non-diabetic ones and the differences were statistically 
evaluated. In diabetic samples the pattern of melatonin staining was unchanged with 
respect to non-diabetic ones, as the gold particles were specifically localized within 
secretory granules and vesicles of serous cells. The quantitative evaluation of gold 
particles showed that the labeling density changed in parotid diabetic samples with 
respect to those measured in non-diabetics, as the percentage of melatonin positive 
granules showed a tendency to decrease in the diabetic status in both glands.
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